ST
Insider
Seshu Tyagarajan
Chief Technology OfficerSeshu Tyagarajan (Chief Technology Officer) filed 4 Form 4 reports in the past 24 months (0 purchases, 4 sales, 1 filed past the two-business-day deadline), most often in Candel Therapeutics, Inc. (CADL). The largest single filing was $276K of CADL (31,278 sh × $8.82, as filed), executed Mar 17 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$775K
shares × price, as filed
Last traded
Mar 17 2025
Filed Mar 19 2025
Median ADV $19.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $775K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 24 months
Most traded names
CADLRecent filings
CADLSALE
Candel Therapeutics, Inc.
View filing →
$276K31,278 sh × $8.82
Exec Mar 17 2025
Filed Mar 19 2025 · 5:30 PM ET CADLSALE Candel Therapeutics, Inc. View filing → $276K
31,278 sh × $8.82
Exec Mar 17 2025
Filed Mar 20 2025 · 5:30 PM ET † CADLSALE Candel Therapeutics, Inc. View filing → $104K
14,322 sh × $7.23
Exec Jan 15 2025
Filed Jan 17 2025 · 5:30 PM ET CADLSALE Candel Therapeutics, Inc. View filing → $120K
14,545 sh × $8.22
Exec Jan 8 2025
Filed Jan 10 2025 · 5:30 PM ET